LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants

  • Kathryn Westendorf
  • , Stefanie Žentelis
  • , Lingshu Wang
  • , Denisa Foster
  • , Peter Vaillancourt
  • , Matthew Wiggin
  • , Erica Lovett
  • , Robin van der Lee
  • , Jörg Hendle
  • , Anna Pustilnik
  • , J. Michael Sauder
  • , Lucas Kraft
  • , Yuri Hwang
  • , Robert W. Siegel
  • , Jinbiao Chen
  • , Beverly A. Heinz
  • , Richard E. Higgs
  • , Nicole L. Kallewaard
  • , Kevin Jepson
  • , Rodrigo Goya
    • Maia A. Smith, David W. Collins, Davide Pellacani, Ping Xiang, Valentine de Puyraimond, Marketa Ricicova, Lindsay Devorkin, Caitlin Pritchard, Aoise O'Neill, Kush Dalal, Pankaj Panwar, Harveer Dhupar, Fabian A. Garces, Courtney A. Cohen, John M. Dye, Kathleen E. Huie, Catherine V. Badger, Darwyn Kobasa, Jonathan Audet, Joshua J. Freitas, Saleema Hassanali, Ina Hughes, Luis Munoz, Holly C. Palma, Bharathi Ramamurthy, Robert W. Cross, Thomas W. Geisbert, Vineet Menachery, Kumari Lokugamage, Viktoriya Borisevich, Iliana Lanz, Lisa Anderson, Payal Sipahimalani, Kizzmekia S. Corbett, Eun Sung Yang, Yi Zhang, Wei Shi, Tongqing Zhou, Misook Choe, John Misasi, Peter D. Kwong, Nancy J. Sullivan, Barney S. Graham, Tara L. Fernandez, Carl L. Hansen, Ester Falconer, John R. Mascola, Bryan E. Jones, Bryan C. Barnhart

Research output: Contribution to journal › Article › peer-review

289 Scopus citations

Fingerprint

Dive into the research topics of 'LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Immunology and Microbiology

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science